DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 100 filers reported holding DICERNA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,274,187 | +198.2% | 128,905 | +115.7% | 0.45% | +64.5% |
| Q1 2020 | $1,098,048 | +166.9% | 59,774 | +220.1% | 0.27% | +274.0% |
| Q4 2019 | $411,388 | -30.3% | 18,674 | -54.5% | 0.07% | -60.1% |
| Q3 2019 | $589,823 | -8.8% | 41,074 | 0.0% | 0.18% | +1.1% |
| Q2 2019 | $646,916 | +7.5% | 41,074 | 0.0% | 0.18% | +2.8% |
| Q1 2019 | $601,734 | +37.0% | 41,074 | 0.0% | 0.18% | -26.1% |
| Q4 2018 | $439,081 | -43.7% | 41,074 | -19.6% | 0.24% | -30.4% |
| Q3 2018 | $779,389 | -25.1% | 51,074 | -39.9% | 0.34% | -28.2% |
| Q2 2018 | $1,041,250 | – | 85,000 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 2,005,238 | $16,463,000 | 5.12% |
| Abingworth LLP | 945,757 | $7,755,000 | 4.53% |
| RA Capital Management | 2,428,571 | $19,939,000 | 2.86% |
| Omega Fund Management, LLC | 223,457 | $1,835,000 | 1.03% |
| DAFNA Capital Management LLC | 123,500 | $1,014,000 | 1.01% |
| Iguana Healthcare Management, LLC | 100,000 | $821,000 | 0.32% |
| Cormorant Asset Management, LP | 245,000 | $2,011,000 | 0.32% |
| Eventide Asset Management | 315,300 | $2,589,000 | 0.15% |
| AWM Investment Company, Inc. | 80,000 | $657,000 | 0.13% |
| Palo Alto Investors LP | 267,890 | $2,199,000 | 0.11% |